LabTurbo Biotech Corporation

As of June 30, 2025, LabTurbo Biotech Corporation carries a market capitalization of 980.41M, placing it among publicly traded companies globally. Its enterprise value stands at 198.36M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2025, LabTurbo Biotech Corporation has 47.94M shares outstanding.

These figures are as of June 30, 2025.

As of June 30, 2025, LabTurbo Biotech Corporation maintains a current ratio of 14.89, meaning it holds 14.9x the short-term assets needed to cover near-term liabilities.

As of the close on October 13, 2026, LabTurbo Biotech Corporation's stock has declined approximately 9.80% over the past 52 weeks. The 50-day moving average sits at 22.91, while the 200-day moving average is 23.75.

As of June 30, 2025, LabTurbo Biotech Corporation holds 806.62M in cash and equivalents against 24.58M in total debt, resulting in a net debt position of -427.43M. Total book value stands at 1.21B, with working capital of 870.31M providing operational flexibility.